Naturally Splendid Looks at Hemp Based Cannabinoid Opportunities

Naturally Splendid Enterprises (TSXV:NSP,FWB:50N) is currently evaluating multiple opportunities in the commercialization of industrial hemp and extracted cannabinoids for nutraceutical products.

As quoted in the press release:

Naturally Splendid is currently in advanced stage discussions with Boreal Technologies (Formerly Canadian Medical Hemp) regarding mutually exclusive licensing of new nutraceutical cannabinoid technologies. These nutraceutical cannabinoid technologies include Cannabidiol (CBD) known for its multiple therapeutic applications without the “stoned” effect of THC found in marijuana.

Naturally Splendid CEO, Craig Goodwin, said:

We are developing business strategies designed to investigate, evaluate and where there is a strong business case, develop additional products and markets unlocking all potential revenue opportunities within the industrial hemp crop. The area of nutraceutical cannabinoids is increasingly interesting to Naturally Splendid, especially when you consider the advanced science being developed by our existing business partner Boreal Technologies. This potential expansion of our relationship with Boreal to include Naturally Splendid’s branded nutraceutical cannabinoid products legally derived from industrial hemp, will allow Naturally Splendid to participate more directly in this nutraceutical market in the United States.

Click here to read the Naturally Splendid Enterprises (TSXV:NSP,FWB:50N) press release
Click here to see the Naturally Splendid Enterprises (TSXV:NSP,FWB:50N) profile.